Disc Medicine, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 10 →InsidersNo open-market buys. 11 insiders sold $119.6M, 63 of 114 sales on a 10b5-1 plan.→HoldersFMR 12.8%BlackRock 6.4%Ra 6.4%→PeersClosest companies: KROS, TNYA, NRIX→
From the filings
Figures
- Net income
- −$245.9Mlast 12 months
- Operating cash flow
- −$201.3Mlast 12 months
- Cash and equivalents
- $98.7Mat the last balance sheet
- Total debt
- $59.3Mat the last balance sheet
- Shares outstanding
- 38.3M shareson issue